Indian pharma has been focusing on innovation and process development to strengthen its capabilities in active pharmaceutical ingredients (APIs). This will see the industry reduce its dependence on ...

As the company strives to maintain its position as a key player in accelerating drug development for biopharma clients ... potentially leading to slower growth in the coming quarters. What risks does ...